Abstract
Inflammatory breast cancer (IBC) is a rare breast malignancy that is associated with poor long-term outcomes despite aggressive surgical and chemotherapeutic interventions. We recently treated a 56-year-old woman with right-sided IBC and biopsy-proven cutaneous metastases to her back and left breast. She underwent chemotherapy, bilateral modified radical mastectomy, and radiation therapy. One year after diagnosis, she is currently disease-free based on positron-emission tomography (PET) imaging and repeat skin biopsies. To provide insight into the management of IBC, we present this interesting case with a reflection on important lessons to be learned.
Copyright © 2012 Association of Program Directors in Surgery. Published by Elsevier Inc. All rights reserved.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biopsy, Needle
-
Breast Neoplasms / pathology*
-
Breast Neoplasms / therapy
-
Carcinoma, Ductal, Breast / pathology*
-
Carcinoma, Ductal, Breast / therapy
-
Chemotherapy, Adjuvant
-
Combined Modality Therapy
-
Diagnostic Imaging / methods
-
Female
-
Follow-Up Studies
-
Humans
-
Immunohistochemistry
-
Inflammatory Breast Neoplasms / diagnosis*
-
Inflammatory Breast Neoplasms / therapy
-
Magnetic Resonance Imaging / methods
-
Mammography / methods
-
Mastectomy, Modified Radical / methods
-
Mastectomy, Segmental
-
Middle Aged
-
Monitoring, Physiologic / methods
-
Neoadjuvant Therapy / methods
-
Neoplasm Staging
-
Neoplasms, Multiple Primary / diagnosis*
-
Neoplasms, Multiple Primary / therapy
-
Positron-Emission Tomography / methods
-
Radiotherapy, Adjuvant
-
Risk Assessment
-
Skin Neoplasms / diagnosis*
-
Skin Neoplasms / therapy
-
Treatment Outcome